The first CRISPR Therapeutics AG trade was made in Q2 2018.
Since then Jim Simons bought shares nine more times and sold shares on eleven occasions. The investor completely sold their stake between Q1 2023 and Q4 2023.
Avg closing price
Price range
Sold -143 Thousand shares
Q4 2023
Avg closing price
$55.28
Price range
$38.62
-
$72.18
Sold 50.3% shares (-145 Thousand shares)
Q3 2023
Avg closing price
$51.65
Price range
$45.39
-
$59.00
Sold 41.9% shares (-207 Thousand shares)
Q2 2023
Avg closing price
$56.74
Price range
$43.47
-
$67.77
Sold 37.1% shares (-291 Thousand shares)
Q1 2023
Avg closing price
$48.57
Price range
$41.00
-
$56.12
Increased shares by 32.6% (+193 Thousand shares)
Q4 2022
Avg closing price
$53.05
Price range
$39.19
-
$65.67
Increased shares by 4.3% (+24.6 Thousand shares)
Q3 2022
Avg closing price
$72.47
Price range
$61.10
-
$83.78
Sold 19.0% shares (-134 Thousand shares)
Q2 2022
Avg closing price
$58.79
Price range
$43.23
-
$73.83
Increased shares by 21.3% (+123 Thousand shares)
Q1 2022
Avg closing price
$62.79
Price range
$53.19
-
$79.24
New holding (+579 Thousand shares)
Q4 2021
Avg closing price
$87.36
Price range
$70.09
-
$111.29
Sold -123 Thousand shares
Q2 2021
Avg closing price
$121.62
Price range
$100.84
-
$161.89
Sold 19.6% shares (-30.1 Thousand shares)
Q1 2021
Avg closing price
$151.00
Price range
$110.72
-
$210.04
Sold 61.2% shares (-242 Thousand shares)
Q4 2020
Avg closing price
$118.20
Price range
$79.67
-
$173.23
Increased shares by 7.1% (+26 Thousand shares)
Q3 2020
Avg closing price
$88.70
Price range
$78.50
-
$100.64
Sold 27.6% shares (-141 Thousand shares)
Q2 2020
Avg closing price
$58.47
Price range
$38.50
-
$76.05
Increased shares by 29.0% (+115 Thousand shares)
Q1 2020
Avg closing price
$51.63
Price range
$33.68
-
$62.53
Increased shares by 904.0% (+355 Thousand shares)
Q4 2019